Early initiation of highly active antiretroviral therapies for AIDS: Dynamic choice with endogenous and exogenous learning
AbstractCriteria for initiation of highly active antiretroviral treatments (HAART) in HIV-infected patients remain a matter of debate world-wide because short-term benefits have to be balanced with costs of these therapies, and restrictions placed on future treatment options if resistant viral strains develop. On the other hand, postponing the introduction of HAART may involve a therapeutic opportunity cost if a patientâs health is allowed to deteriorate to such an extent of becoming unable to benefit from new treatments currently under development when they become available. We introduce a two period model where period one treatment adoption is an irreversible act with future, but uncertain, consequences. New information, both endogenous and exogenous, arises over time and shapes the conditions surrounding the second period therapeutic decision. A surprising result is that, under conditions that appear close to those surrounding the HAART debate, the magnitude of the feared resistance effect has no effect on leaves the optimal treatment decision as far as it is high enough. Le bien-fondÃ© dâadministrer prÃ©cocement des traitements antirÃ©troviraux Ã haute activitÃ© (HAART) aux personnes infectÃ©es par le VIH reste objet de dÃ©bats dans le monde, car leurs bienfaits Ã court terme peuvent compromettre les traitements futurs si se dÃ©veloppent des souches rÃ©sistantes du virus. Par ailleurs retarder le recours aux HAART comporte un coÃ»t dâopportunitÃ© thÃ©rapeutique si la santÃ© du patient se dÃ©grade au point quâil ne peut plus bÃ©nÃ©ficier par la suite des traitements encore en cours de dÃ©veloppement. Nous formulons un modÃ¨le Ã deux pÃ©riodes oÃ¹ lâadoption du traitement de premiÃ¨re pÃ©riode est irrÃ©versible et engage le futur, alors que des informations et connaissances nouvelles, exogÃ¨nes et endogÃ¨nes, dÃ©terminent les conditions entourant la dÃ©cision thÃ©rapeutique de deuxiÃ¨me pÃ©riode. Paradoxalement, sous des conditions reflÃ©tant bien les enjeux
Download InfoIf you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
Bibliographic InfoArticle provided by Elsevier in its journal Journal of Health Economics.
Volume (Year): 25 (2006)
Issue (Month): 3 (May)
Contact details of provider:
Web page: http://www.elsevier.com/locate/inca/505560
Other versions of this item:
- Pierre Lasserre & Jean-Paul Moatti & Antoine Soubeyran, 2005. "Early Initiation of Highly Active Antiretroviral Therapies for Aids: Dynamic choice with Endogenous and Exogenous Learning," CIRANO Working Papers 2005s-34, CIRANO.
- I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health
- C61 - Mathematical and Quantitative Methods - - Mathematical Methods; Programming Models; Mathematical and Simulation Modeling - - - Optimization Techniques; Programming Models; Dynamic Analysis
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
- Giuseppe Moscarini & Lones Smith, 2001. "The Optimal Level of Experimentation," Econometrica, Econometric Society, vol. 69(6), pages 1629-1644, November.
- Geoffard, P.Y. & Philipson, T., 1995.
"Rational Epidemics and their Public Control,"
DELTA Working Papers
95-15, DELTA (Ecole normale supérieure).
- Kassar, Ilhem & Lasserre, Pierre, 2004.
"Species preservation and biodiversity value: a real options approach,"
Journal of Environmental Economics and Management,
Elsevier, vol. 48(2), pages 857-879, September.
- Ilhem Kassar & Pierre Lasserre, 2002. "Species Preservation and Biodiversity Value: A Real Options Approach," CIRANO Working Papers 2002s-82, CIRANO.
- Ilhem Kassar & Pierre Lasserre, 2002. "Species Preservation and Biodiversity Value: A Real Options Approach," Cahiers de recherche du DÃ©partement des sciences Ã©conomiques, UQAM 20-18, Université du Québec à Montréal, Département des sciences économiques.
- Rossella Levaggi & Michele Moretto, 2007.
"Investment in hospital care technology under different purchasing rules: a real option approach,"
"Marco Fanno" Working Papers
0046, Dipartimento di Scienze Economiche "Marco Fanno".
- Rosella Levaggi & Moretto Michele, 2008. "Investment In Hospital Care Technology Under Different Purchasing Rules: A Real Option Approach," Bulletin of Economic Research, Wiley Blackwell, vol. 60(2), pages 159-181, 04.
- Michele Moretto & Rosella Levaggi, 2004. "Investment in Hospital Care Technology under Different Purchasing Rules: A Real Option Approach," Working Papers 2004.75, Fondazione Eni Enrico Mattei.
- Palmer, Stephen & Smith, Peter C., 2000. "Incorporating option values into the economic evaluation of health care technologies," Journal of Health Economics, Elsevier, vol. 19(5), pages 755-766, September.
- Paolo Pertile, 2009. "An extension of the real option approach to the evaluation of health care technologies: the case of positron emission tomography," International Journal of Health Care Finance and Economics, Springer, vol. 9(3), pages 317-332, September.
- Leoni, Patrick & Luchini, Stéphane, 2011. "Designing the financial tools to promote universal access to AIDS care," Journal of Health Economics, Elsevier, vol. 30(1), pages 181-188, January.
- Paolo Pertile & Emanuele Torri & Luciano Flor & Stefano Tardivo, 2009. "The timing of adoption of positron emission tomography: a real options approach," Health Care Management Science, Springer, vol. 12(3), pages 217-227, September.
- Meyer, Elisabeth & Rees, Ray, 2012. "Watchfully waiting: Medical intervention as an optimal investment decision," Journal of Health Economics, Elsevier, vol. 31(2), pages 349-358.
If references are entirely missing, you can add them using this form.